Friday, November 15th, 2019
Paul Bledsoe in the Washington Post

“Bloomberg's climate advocacy has been second to none,” said Paul Bledsoe, a former Clinton White House climate adviser who now works with the Progressive Policy Institute. But what are his chances of winning the nomination?
Tressa Pankovits in the PPI Blog

We thought it would be worth adding this note to what has been a full-throated and well-deserved chorus of derision for Senator Warren's abject capitulation to the teachers unions and education in America.
The Prescription Escalator: The Real Reason Why Americans Pay More for Drugs Each Year, Why They Are So Upset, and What Can Be Done About It
by Dr. Michael Mandel, Chief Economic Strategist at the Progressive Policy Institute

In this paper we will introduce a new concept, the “prescription escalator.” The prescription escalator is a simple way of summarizing why Americans are so upset about their drug bills. Moreover, we propose solutions for getting Americans off the prescription escalator. Americans know, without a doubt, that their family’s prescription drug costs are rising—and they are angry. A survey commissioned in fall 2018 by the Progressive Policy Institute found that 83% of Americans worry that drug companies are “charging too much.”
 
The poll also found that 73% of Americans have negative feelings about drug companies. Other polls corroborate these feelings, leading to multiple Congressional hearings and legislative proposals.